Elanco Acquires Canadian Vaccine Maker

(Image courtesy of Elanco Animal Health)

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) has acquired a Canadian biotech startup that specializes in vaccines for food animals. Elanco announced Thursday it acquired Montreal-based Prevtech Microbia Inc. in an all-cash deal of nearly $60 million.

The two companies already had a relationship as Elanco has exclusive rights to distribute a product line of swine vaccines called Coliprotec in Canada and Europe.

“Elanco’s partnership with Prevtec has been very successful and has resulted in delivery of an important non-antibiotic solution for swine producers,” said Ramiro Cabral, executive vice president of International for Elanco.

Coliprotec is designed to protect young pigs from severe diarrhea which affects about half of all weaned pigs. Untreated, diarrhea in pigs can suppress appetite, weight loss, and even mortality.